Synthesis and secretion of vascular permeability factor/vascular endothelial growth factor by human retinal pigment epithelial cells
- PMID: 8512562
- DOI: 10.1006/bbrc.1993.1671
Synthesis and secretion of vascular permeability factor/vascular endothelial growth factor by human retinal pigment epithelial cells
Abstract
The presence of the secreted angiogenic molecule, vascular permeability factor/vascular endothelial growth factor, was investigated in human retinal pigment epithelial cells. Northern and in situ hybridization analysis of cultured cells identified vascular permeability factor/vascular endothelial growth factor mRNA. Western analysis of cell lysates identified a 42 kD protein that comigrated with human recombinant vascular permeability factor/vascular endothelial growth factor. Immunoassay measurements detected vascular permeability factor/vascular endothelial growth factor protein in cell lysates and conditioned media in vitro and in cell lysates isolated directly from post-mortem eyes. These data demonstrate that human retinal pigment epithelial cells can synthesize the secreted angiogenic peptide vascular permeability factor/vascular endothelial growth factor in vitro and in situ. The production and secretion of this factor by human retinal pigment epithelial cells may be important in the pathogenesis of ocular neovascularization.
Similar articles
-
Hypoxic induction of endothelial cell growth factors in retinal cells: identification and characterization of vascular endothelial growth factor (VEGF) as the mitogen.Mol Med. 1995 Jan;1(2):182-93. Mol Med. 1995. PMID: 8529097 Free PMC article.
-
Angiopoietin-1 upregulation by vascular endothelial growth factor in human retinal pigment epithelial cells.Invest Ophthalmol Vis Sci. 2001 Jun;42(7):1617-25. Invest Ophthalmol Vis Sci. 2001. PMID: 11381069
-
Advanced glycation end products increase retinal vascular endothelial growth factor expression.J Clin Invest. 1998 Mar 15;101(6):1219-24. doi: 10.1172/JCI1277. J Clin Invest. 1998. PMID: 9502762 Free PMC article.
-
Endothelial and glial cell interaction in diabetic retinopathy via the function of vascular endothelial growth factor (VEGF).Pol J Pharmacol. 1996 May-Jun;48(3):307-16. Pol J Pharmacol. 1996. PMID: 9112668 Review.
-
The pathogenesis of edema in diabetic maculopathy.Semin Ophthalmol. 1999 Dec;14(4):223-32. doi: 10.3109/08820539909069541. Semin Ophthalmol. 1999. PMID: 10758223 Review.
Cited by
-
Role of vascular permeability factor/vascular endothelial growth factor in eye disease.Br J Ophthalmol. 1997 Jun;81(6):501-12. doi: 10.1136/bjo.81.6.501. Br J Ophthalmol. 1997. PMID: 9274417 Free PMC article. Review. No abstract available.
-
Increased expression of angiogenic growth factors in age-related maculopathy.Br J Ophthalmol. 1997 Feb;81(2):154-62. doi: 10.1136/bjo.81.2.154. Br J Ophthalmol. 1997. PMID: 9059252 Free PMC article.
-
Suppression of retinal neovascularization in vivo by inhibition of vascular endothelial growth factor (VEGF) using soluble VEGF-receptor chimeric proteins.Proc Natl Acad Sci U S A. 1995 Nov 7;92(23):10457-61. doi: 10.1073/pnas.92.23.10457. Proc Natl Acad Sci U S A. 1995. PMID: 7479819 Free PMC article.
-
Ten years of anti-vascular endothelial growth factor therapy.Nat Rev Drug Discov. 2016 Jun;15(6):385-403. doi: 10.1038/nrd.2015.17. Epub 2016 Jan 18. Nat Rev Drug Discov. 2016. PMID: 26775688
-
Relationship between RPE and choriocapillaris in age-related macular degeneration.Invest Ophthalmol Vis Sci. 2009 Oct;50(10):4982-91. doi: 10.1167/iovs.09-3639. Epub 2009 Apr 8. Invest Ophthalmol Vis Sci. 2009. PMID: 19357355 Free PMC article.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources